Common Contracts
3 similar Registration Rights Agreement contracts by Sorrento Therapeutics, Inc.
EXECUTION VERSION SORRENTO THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 5th, 2020 • California
This Registration Rights Agreement (this “Agreement”) is made as of April 27, 2017, by and among Sorrento Therapeutics, Inc., a Delaware corporation (the “Company”), and the shareholders of Virttu Biologics Limited, a private company limited by shares incorporated in England and Wales (“Virttu”) set forth on Schedule A hereto (each a “Shareholder,” and collectively, the “Shareholders”) and such other Persons, if any, from time to time, that become a party hereto as holders of Registrable Securities (as defined below). Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in that certain Share Purchase Agreement dated as of April 27, 2017 by and among TNK Therapeutics, Inc., the Company, Virttu, the Shareholders, Dayspring Ventures Limited, not individually but solely in its capacity as the Shareholders’ Representative and, solely with respect to certain sections thereof, Sorrento Therapeutics, Inc. (as may be amended or restated fr
SORRENTO THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 28th, 2017 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • California
This Registration Rights Agreement (this “Agreement”) is made as of April 27, 2017, by and among Sorrento Therapeutics, Inc., a Delaware corporation (the “Company”), and the shareholders of Virttu Biologics Limited, a private company limited by shares incorporated in England and Wales (“Virttu”) set forth on Schedule A hereto (each a “Shareholder,” and collectively, the “Shareholders”) and such other Persons, if any, from time to time, that become a party hereto as holders of Registrable Securities (as defined below). Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in that certain Share Purchase Agreement dated as of April 27, 2017 by and among TNK Therapeutics, Inc., the Company, Virttu, the Shareholders, Dayspring Ventures Limited, not individually but solely in its capacity as the Shareholders’ Representative and, solely with respect to certain sections thereof, Sorrento Therapeutics, Inc. (as may be amended or restated fr
SORRENTO THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 8th, 2016 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • California
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of November 8, 2016, by and among Sorrento Therapeutics, Inc., a Delaware corporation (the “Company”), and the stockholders of Scilex Pharmaceuticals Inc., a Delaware corporation (“Scilex”) set forth on SCHEDULE A hereto (each a “Stockholder,” and collectively, the “Stockholders”) and such other Persons, if any, from time to time, that become a party hereto as holders of Registrable Securities (as defined below). Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in that certain Stock Purchase Agreement dated as of November 8, 2016 by and among the Company, Scilex, the Stockholders and SPI Shareholders Representative, LLC, a Delaware limited liability company, as the Stockholders’ Representative (as may be amended or restated from time to time, the “Purchase Agreement”).
